{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:30Z","timestamp":1786119210170,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7,17]]},"DOI":"10.1097\/qad.0b013e32832c165c","type":"journal-article","created":{"date-parts":[[2009,6,29]],"date-time":"2009-06-29T03:22:54Z","timestamp":1246245774000},"page":"1425-1429","source":"Crossref","is-referenced-by-count":15,"title":["CMV DNA levels and CMV gB subtypes in ART-naive HAART-treated patients: a 2-year follow-up study in The Netherlands"],"prefix":"10.1097","volume":"23","author":[{"given":"Val\u00e8re J","family":"Goossens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra F","family":"Wolffs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge H","family":"van Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathrien A","family":"Bruggeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Verbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210130","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R2-16-20210130","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1001\/jama.282.23.2220","article-title":"AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study","volume":"282","author":"Ledergerber","year":"1999","journal-title":"JAMA"},{"key":"R3-16-20210130","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcv.2005.10.016","article-title":"CMV as a cofactor enhancing progression of AIDS","volume":"35","author":"Griffiths","year":"2006","journal-title":"J Clin Vir"},{"key":"R4-16-20210130","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1378\/chest.120.6.1888","article-title":"Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy","volume":"120","author":"Wolff","year":"2001","journal-title":"Chest"},{"key":"R5-16-20210130","first-page":"186","article-title":"Cytomegalovirus retinitis after immune reconstitution","volume":"15","author":"Crum","year":"2005","journal-title":"AIDS Read"},{"key":"R6-16-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2006.03.005","article-title":"Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART)","volume":"37","author":"Steininger","year":"2006","journal-title":"J Clin Virology"},{"key":"R7-16-20210130","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1001\/archinte.161.16.1962","article-title":"Limited patient adherence to highly activate antiretroviral therapy for HIV-1 infection in an observational cohort","volume":"161","author":"Nieuwkerk","year":"2001","journal-title":"Arch Intern Med"},{"key":"R8-16-20210130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1386-6532(00)00188-8","article-title":"CMV gB genotypes and outcome of vertical transmission: study on dried blood spots of congenitally infected babies","volume":"21","author":"Barbi","year":"2001","journal-title":"J Clin Virol"},{"key":"R9-16-20210130","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1128\/JCM.41.7.2872-2877.2003","article-title":"Different cytomegalovirus glycoprotein B genotype distribution in serum and cerebrospinal fluid specimens determined by a novel multiplex nested PCR","volume":"41","author":"Tarrago","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R11-16-20210130","first-page":"2","article-title":"Opportunistic infections: an update","volume":"7","author":"Furrer","year":"2002","journal-title":"J HIV Ther"},{"key":"R12-16-20210130","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1128\/JCM.37.9.2804-2807.1999","article-title":"Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation","volume":"37","author":"Aitken","year":"1999","journal-title":"J Clin Microbiol"},{"key":"R13-16-20210130","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1086\/514145","article-title":"Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient seorstatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation","volume":"176","author":"Cope","year":"1997","journal-title":"J Infect Dis"},{"key":"R14-16-20210130","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.bmt.1701139","article-title":"Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor\/recipient serostatus, acute GVHD and CMV disease","volume":"21","author":"Gor","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"R15-16-20210130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/375843","article-title":"Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS clinical trials group protocol 360)","volume":"37","author":"Erice","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R16-16-20210130","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00002030-199707000-00008","article-title":"Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease","volume":"11","author":"Bowen","year":"1997","journal-title":"AIDS"},{"key":"R17-16-20210130","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1128\/JVI.73.8.7027-7030.1999","article-title":"Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS","volume":"73","author":"Spector","year":"1999","journal-title":"J Virol"},{"key":"R18-16-20210130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.2008.697","article-title":"Cytomegalovirus reactivation in critically ill immunocompetent patients","volume":"300","author":"Limaye","year":"2008","journal-title":"JAMA"},{"key":"R19-16-20210130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-6405-4-9","article-title":"Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options","volume":"4","author":"Murdoch","year":"2007","journal-title":"AIDS Res Ther"},{"key":"R20-16-20210130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00003495-200868020-00004","article-title":"Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy","volume":"68","author":"Dhasmana","year":"2008","journal-title":"Drugs"},{"key":"R21-16-20210130","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1086\/323898","article-title":"Clinical indicators of immune restoration following highly active antiretroviral therapy","volume":"34","author":"Cooney","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R22-16-20210130","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1086\/313809","article-title":"Immunorestitution disease involving the innate and adaptive response","volume":"30","author":"Cheng","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R23-16-20210130","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/00365549609037937","article-title":"Glycoprotein B genotype of human cytomegalovirus: distribution in HIV infected patients","volume":"28","author":"Bongarts","year":"1996","journal-title":"Scand J Infect Dis"},{"key":"R25-16-20210130","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/infdis\/174.1.184","article-title":"Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS patients","volume":"174","author":"Shepp","year":"1996","journal-title":"J Infect Dis"},{"key":"R26-16-20210130","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/aid.1998.14.533","article-title":"Geographic and demographic differences in the frequency of human cytomegalovirus gB genotypes 1-4 in immunocompromised patients","volume":"14","author":"Zipeto","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R27-16-20210130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jmv.10549","article-title":"Onset and duration of cytomegalovirus immediate early 1 mRNA expression in the blood of renal transplant recipients","volume":"72","author":"Goossens","year":"2004","journal-title":"J Med Virol"},{"key":"R28-16-20210130","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJM200105033441804","article-title":"Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity","volume":"344","author":"Boppana","year":"2001","journal-title":"N Engl J Med"},{"key":"R29-16-20210130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/infdis\/160.1.11","article-title":"Reactivation and recombination of multiple cytomegalovirus strains from individual organ donors","volume":"160","author":"Chou","year":"1989","journal-title":"J Infect Dis"},{"key":"R30-16-20210130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/infdis\/160.1.16","article-title":"Neutralizing antibody responses to reinfecting strains of cytomegalovirus in transplant recipients","volume":"160","author":"Chou","year":"1989","journal-title":"J Infect Dis"},{"key":"R31-16-20210130","first-page":"2228","article-title":"High variability of cytomegalovirus glycoprotein B gene and frequent multiple infections in HIV-infected patients with low CD4 T-cell count","volume":"12","author":"Meyer-Konig","year":"1998","journal-title":"AIDS"},{"key":"R32-16-20210130","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0140-6736(05)70487-6","article-title":"Simultaneous infection of healthy people with multiple human cytomegalovirus strains","volume":"352","author":"Meyer-Konig","year":"1998","journal-title":"Lancet"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200907170-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:59:51Z","timestamp":1786039191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200907170-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,17]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32832c165c","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7,17]]}}}